
Pathway Acquired by Doximity for $63 Million to Enhance AI Clinical Tools
News Summary
San Francisco-based telehealth firm Doximity has acquired Montréal-based healthtech startup Pathway Medical for $63 million USD ($87 million CAD). The acquisition includes $26 million in cash and up to $37 million in equity grants. Pathway, known for its AI-powered search engine of vetted medical information, will have all six of its employees, including physicians, join Doximity’s team. This acquisition is expected to strengthen Doximity’s clinical reference capabilities by integrating Pathway’s extensive medical dataset into its platform. Doximity, which serves over 80% of US physicians, aims to provide advanced clinical tools by combining trusted medical evidence with AI adaptability. The joint product with Pathway’s technology is currently in beta testing with thousands of doctors. Pathway, founded in 2018, has raised $6.3 million USD in total funding from investors like Yamaha Motor Ventures and Desjardins Venture Capital.




